Semaglutide medicines review concluded, review of two chickenpox vaccines started
ICH guidance released for public consultation until 15 September 2025
Measures minimise risk of suicidal thoughts
Vaccine must not be used in people 65 years and above
Public consultation open until end September 2025
Seizing opportunities in a changing medicines landscape
Find medicine
What's new
FAQs
Latest news
Treatment with semaglutide should be stopped if NAION occurs
EMA concludes review of semaglutide medicines and starts review of two chickenpox vaccines
The European Medicines Agency (EMA) is closed from 18:00 on Friday 6 June until 08:30 on Tuesday 10 June
Recommendations will support better information on benefits and risks of medicines in this population
Ten new medicines recommended for approval; another four medicines recommended for extension of their therapeutic indications
Recommendations aim to optimise use and minimise development of antimicrobial resistance
Information for you
Patients and carers
Healthcare professionals
Animal health professionals
Pharmaceutical Industry
Media
